VTYX Latest Headlines

Class Action Investigation Targets Ventyx Biosciences After Strategic Shift in Phase 2 Trial Timeline

Market Chameleon (Wed, 7-Jan 10:29 AM)

Ventyx Biosciences Faces Legal Investigation Amid Delays in Phase 2 Study—Key Takeaways for Investors

Market Chameleon (Fri, 2-Jan 11:58 AM)

Ventyx Expands Global Phase 2 Study for VTX2735 and Strengthens Advisory Team Ahead of Key Data Milestones

Market Chameleon (Tue, 2-Dec 8:12 AM)

VTX3232 Shows Landmark Reduction in Cardiovascular Inflammation Without Weight Loss Impact: Ventyx Biosciences Phase 2 Results Explained

Market Chameleon (Thu, 23-Oct 9:53 AM)

VTX3232 Achieves 78% Reduction in hsCRP: Phase 2 Study Spotlights New Path in Cardiovascular Risk

Market Chameleon (Thu, 23-Oct 7:06 AM)